1. Home
  2. KORE vs LTRN Comparison

KORE vs LTRN Comparison

Compare KORE & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KORE
  • LTRN
  • Stock Information
  • Founded
  • KORE 2003
  • LTRN 2013
  • Country
  • KORE United States
  • LTRN United States
  • Employees
  • KORE N/A
  • LTRN N/A
  • Industry
  • KORE Telecommunications Equipment
  • LTRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • KORE Consumer Discretionary
  • LTRN Health Care
  • Exchange
  • KORE Nasdaq
  • LTRN Nasdaq
  • Market Cap
  • KORE 39.6M
  • LTRN 36.1M
  • IPO Year
  • KORE N/A
  • LTRN 2020
  • Fundamental
  • Price
  • KORE $2.75
  • LTRN $3.09
  • Analyst Decision
  • KORE Hold
  • LTRN Strong Buy
  • Analyst Count
  • KORE 2
  • LTRN 1
  • Target Price
  • KORE $2.75
  • LTRN $25.00
  • AVG Volume (30 Days)
  • KORE 11.1K
  • LTRN 71.9K
  • Earning Date
  • KORE 05-15-2025
  • LTRN 05-15-2025
  • Dividend Yield
  • KORE N/A
  • LTRN N/A
  • EPS Growth
  • KORE N/A
  • LTRN N/A
  • EPS
  • KORE N/A
  • LTRN N/A
  • Revenue
  • KORE $282,254,000.00
  • LTRN N/A
  • Revenue This Year
  • KORE $4.53
  • LTRN N/A
  • Revenue Next Year
  • KORE $6.86
  • LTRN N/A
  • P/E Ratio
  • KORE N/A
  • LTRN N/A
  • Revenue Growth
  • KORE N/A
  • LTRN N/A
  • 52 Week Low
  • KORE $1.10
  • LTRN $2.55
  • 52 Week High
  • KORE $4.88
  • LTRN $6.40
  • Technical
  • Relative Strength Index (RSI)
  • KORE 56.67
  • LTRN 41.60
  • Support Level
  • KORE $2.33
  • LTRN $2.85
  • Resistance Level
  • KORE $2.57
  • LTRN $3.23
  • Average True Range (ATR)
  • KORE 0.14
  • LTRN 0.37
  • MACD
  • KORE 0.03
  • LTRN -0.07
  • Stochastic Oscillator
  • KORE 86.79
  • LTRN 14.28

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: